APO Research
Talk to an analyst

APO RESEARCH · REPORT

GLP-1 Weight Loss Pill

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global GLP-1 Weight Loss Pill Market Outlook and Growth Opportunities 2026

26 December 2025201 pages

Choose your research edition.

Industry ResearchGLP-1 Weight Loss Pill Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal GLP-1 Weight Loss Pill Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal GLP-1 Weight Loss Pill Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GLP-1 Weight Loss Pill Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal GLP-1 Weight Loss Pill Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global GLP-1 Weight Loss Pill market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for GLP-1 Weight Loss Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for GLP-1 Weight Loss Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GLP-1 Weight Loss Pill is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the GLP-1 Weight Loss Pill market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the GLP-1 Weight Loss Pill market include Novo Nordisk, Reddy's Laboratories, Imeik, Aurisco Pharmaceuticals, Borui Pharmaceuticals, Gan & Lee Pharmaceuticals, Hansoh Pharmaceuticals, Hengrui Medicine and Huadong Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global GLP-1 Weight Loss Pill market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of GLP-1 Weight Loss Pill and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents GLP-1 Weight Loss Pill sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GLP-1 Weight Loss Pill market size, projected growth trends, production technologies, key applications, and end-use industries.

GLP-1 Weight Loss Pill Segment by Company

Novo Nordisk

Reddy's Laboratories

Imeik

Aurisco Pharmaceuticals

Borui Pharmaceuticals

Gan & Lee Pharmaceuticals

Hansoh Pharmaceuticals

Hengrui Medicine

Huadong Medicine

Eli Lilly

Merck

Shanghai Benemae Biopharmaceuticals Co., Ltd.

CSPC Pharmaceuticals

Sihuan Pharmaceuticals

Wanbang Biopharma

Innovent Biologics

GLP-1 Weight Loss Pill Segment by Type

Oral

Injection

GLP-1 Weight Loss Pill Segment by Application

Clinic

Hospital

Pharmacy

Others

GLP-1 Weight Loss Pill Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global GLP-1 Weight Loss Pill status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions GLP-1 Weight Loss Pill market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify GLP-1 Weight Loss Pill significant trends, drivers, influence factors in global and regions.

6. To analyze GLP-1 Weight Loss Pill competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Weight Loss Pill market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Weight Loss Pill and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Weight Loss Pill.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the GLP-1 Weight Loss Pill market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GLP-1 Weight Loss Pill industry.

Chapter 3: Detailed analysis of GLP-1 Weight Loss Pill manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of GLP-1 Weight Loss Pill in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of GLP-1 Weight Loss Pill in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. GLP-1 Weight Loss Pill Industry Trends Table 2. GLP-1 Weight Loss Pill Industry Drivers Table 3. GLP-1 Weight Loss Pill Industry Opportunities and Challenges Table 4. GLP-1 Weight Loss Pill Industry Restraints Table 5. Global GLP-1 Weight Loss Pill Revenue by Company (US$ Million) & (2021-2026) Table 6. Global GLP-1 Weight Loss Pill Revenue Share by Company (2021-2026) Table 7. Global GLP-1 Weight Loss Pill Sales Volume by Company (K Units) & (2021-2026) Table 8. Global GLP-1 Weight Loss Pill Sales Volume Share by Company (2021-2026) Table 9. Global GLP-1 Weight Loss Pill Average Price (US$/Unit) of Company (2021-2026) Table 10. Global GLP-1 Weight Loss Pill Company Ranking, (2024-2026) & (USD Million) Table 11. Global GLP-1 Weight Loss Pill Key Company Manufacturing Base & Headquarters Table 12. Global GLP-1 Weight Loss Pill Company, Product Type & Application Table 13. Global GLP-1 Weight Loss Pill Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global GLP-1 Weight Loss Pill by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Oral Table 18. Significant Companies of Injection Table 19. Global GLP-1 Weight Loss Pill Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global GLP-1 Weight Loss Pill Sales Volume by Type (2021-2026) & (K Units) Table 21. Global GLP-1 Weight Loss Pill Sales Volume by Type (2027-2032) & (K Units) Table 22. Global GLP-1 Weight Loss Pill Sales Volume Share by Type (2021-2026) Table 23. Global GLP-1 Weight Loss Pill Sales Volume Share by Type (2027-2032) Table 24. Global GLP-1 Weight Loss Pill Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global GLP-1 Weight Loss Pill Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global GLP-1 Weight Loss Pill Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global GLP-1 Weight Loss Pill Sales Value Share by Type (2021-2026) Table 28. Global GLP-1 Weight Loss Pill Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Pharmacy Table 32. Significant Companies of Others Table 33. Global GLP-1 Weight Loss Pill Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global GLP-1 Weight Loss Pill Sales Volume by Application (2021-2026) & (K Units) Table 35. Global GLP-1 Weight Loss Pill Sales Volume by Application (2027-2032) & (K Units) Table 36. Global GLP-1 Weight Loss Pill Sales Volume Share by Application (2021-2026) Table 37. Global GLP-1 Weight Loss Pill Sales Volume Share by Application (2027-2032) Table 38. Global GLP-1 Weight Loss Pill Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global GLP-1 Weight Loss Pill Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global GLP-1 Weight Loss Pill Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global GLP-1 Weight Loss Pill Sales Value Share by Application (2021-2026) Table 42. Global GLP-1 Weight Loss Pill Sales Value Share by Application (2027-2032) Table 43. Global GLP-1 Weight Loss Pill Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global GLP-1 Weight Loss Pill Sales by Region (2021-2026) & (K Units) Table 45. Global GLP-1 Weight Loss Pill Sales Market Share by Region (2021-2026) Table 46. Global GLP-1 Weight Loss Pill Sales by Region (2027-2032) & (K Units) Table 47. Global GLP-1 Weight Loss Pill Sales Market Share by Region (2027-2032) Table 48. Global GLP-1 Weight Loss Pill Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global GLP-1 Weight Loss Pill Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global GLP-1 Weight Loss Pill Sales Value Share by Region (2021-2026) Table 51. Global GLP-1 Weight Loss Pill Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global GLP-1 Weight Loss Pill Sales Value Share by Region (2027-2032) Table 53. Global GLP-1 Weight Loss Pill Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global GLP-1 Weight Loss Pill Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global GLP-1 Weight Loss Pill Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global GLP-1 Weight Loss Pill Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global GLP-1 Weight Loss Pill Sales by Country (2021-2026) & (K Units) Table 58. Global GLP-1 Weight Loss Pill Sales Market Share by Country (2021-2026) Table 59. Global GLP-1 Weight Loss Pill Sales by Country (2027-2032) & (K Units) Table 60. Global GLP-1 Weight Loss Pill Sales Market Share by Country (2027-2032) Table 61. Global GLP-1 Weight Loss Pill Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global GLP-1 Weight Loss Pill Sales Value Market Share by Country (2021-2026) Table 63. Global GLP-1 Weight Loss Pill Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global GLP-1 Weight Loss Pill Sales Value Market Share by Country (2027-2032) Table 65. Novo Nordisk Company Information Table 66. Novo Nordisk Business Overview Table 67. Novo Nordisk GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Novo Nordisk GLP-1 Weight Loss Pill Product Portfolio Table 69. Novo Nordisk Recent Development Table 70. Reddy's Laboratories Company Information Table 71. Reddy's Laboratories Business Overview Table 72. Reddy's Laboratories GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Reddy's Laboratories GLP-1 Weight Loss Pill Product Portfolio Table 74. Reddy's Laboratories Recent Development Table 75. Imeik Company Information Table 76. Imeik Business Overview Table 77. Imeik GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Imeik GLP-1 Weight Loss Pill Product Portfolio Table 79. Imeik Recent Development Table 80. Aurisco Pharmaceuticals Company Information Table 81. Aurisco Pharmaceuticals Business Overview Table 82. Aurisco Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Aurisco Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio Table 84. Aurisco Pharmaceuticals Recent Development Table 85. Borui Pharmaceuticals Company Information Table 86. Borui Pharmaceuticals Business Overview Table 87. Borui Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Borui Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio Table 89. Borui Pharmaceuticals Recent Development Table 90. Gan & Lee Pharmaceuticals Company Information Table 91. Gan & Lee Pharmaceuticals Business Overview Table 92. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio Table 94. Gan & Lee Pharmaceuticals Recent Development Table 95. Hansoh Pharmaceuticals Company Information Table 96. Hansoh Pharmaceuticals Business Overview Table 97. Hansoh Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Hansoh Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio Table 99. Hansoh Pharmaceuticals Recent Development Table 100. Hengrui Medicine Company Information Table 101. Hengrui Medicine Business Overview Table 102. Hengrui Medicine GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Hengrui Medicine GLP-1 Weight Loss Pill Product Portfolio Table 104. Hengrui Medicine Recent Development Table 105. Huadong Medicine Company Information Table 106. Huadong Medicine Business Overview Table 107. Huadong Medicine GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Huadong Medicine GLP-1 Weight Loss Pill Product Portfolio Table 109. Huadong Medicine Recent Development Table 110. Eli Lilly Company Information Table 111. Eli Lilly Business Overview Table 112. Eli Lilly GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Eli Lilly GLP-1 Weight Loss Pill Product Portfolio Table 114. Eli Lilly Recent Development Table 115. Merck Company Information Table 116. Merck Business Overview Table 117. Merck GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Merck GLP-1 Weight Loss Pill Product Portfolio Table 119. Merck Recent Development Table 120. Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information Table 121. Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview Table 122. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Pill Product Portfolio Table 124. Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Development Table 125. CSPC Pharmaceuticals Company Information Table 126. CSPC Pharmaceuticals Business Overview Table 127. CSPC Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. CSPC Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio Table 129. CSPC Pharmaceuticals Recent Development Table 130. Sihuan Pharmaceuticals Company Information Table 131. Sihuan Pharmaceuticals Business Overview Table 132. Sihuan Pharmaceuticals GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Sihuan Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio Table 134. Sihuan Pharmaceuticals Recent Development Table 135. Wanbang Biopharma Company Information Table 136. Wanbang Biopharma Business Overview Table 137. Wanbang Biopharma GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Wanbang Biopharma GLP-1 Weight Loss Pill Product Portfolio Table 139. Wanbang Biopharma Recent Development Table 140. Innovent Biologics Company Information Table 141. Innovent Biologics Business Overview Table 142. Innovent Biologics GLP-1 Weight Loss Pill Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. Innovent Biologics GLP-1 Weight Loss Pill Product Portfolio Table 144. Innovent Biologics Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. GLP-1 Weight Loss Pill Distributors List Table 148. GLP-1 Weight Loss Pill Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. GLP-1 Weight Loss Pill Product Image Figure 2. Global GLP-1 Weight Loss Pill Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GLP-1 Weight Loss Pill Sales Value (2021-2032) & (US$ Million) Figure 4. Global GLP-1 Weight Loss Pill Sales (2021-2032) & (K Units) Figure 5. Global GLP-1 Weight Loss Pill Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global GLP-1 Weight Loss Pill Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Oral Image Figure 10. Injection Image Figure 11. Global GLP-1 Weight Loss Pill Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global GLP-1 Weight Loss Pill Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global GLP-1 Weight Loss Pill Sales Volume Share by Type (2021-2032) Figure 14. Global GLP-1 Weight Loss Pill Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global GLP-1 Weight Loss Pill Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global GLP-1 Weight Loss Pill Sales Value Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Pharmacy Image Figure 20. Others Image Figure 21. Global GLP-1 Weight Loss Pill Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global GLP-1 Weight Loss Pill Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global GLP-1 Weight Loss Pill Sales Volume Share by Application (2021-2032) Figure 24. Global GLP-1 Weight Loss Pill Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global GLP-1 Weight Loss Pill Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global GLP-1 Weight Loss Pill Sales Value Share by Application (2021-2032) Figure 27. Global GLP-1 Weight Loss Pill Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global GLP-1 Weight Loss Pill Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global GLP-1 Weight Loss Pill Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global GLP-1 Weight Loss Pill Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America GLP-1 Weight Loss Pill Sales Value (2021-2032) & (US$ Million) Figure 32. North America GLP-1 Weight Loss Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe GLP-1 Weight Loss Pill Sales Value (2021-2032) & (US$ Million) Figure 34. Europe GLP-1 Weight Loss Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific GLP-1 Weight Loss Pill Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific GLP-1 Weight Loss Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America GLP-1 Weight Loss Pill Sales Value (2021-2032) & (US$ Million) Figure 38. South America GLP-1 Weight Loss Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa GLP-1 Weight Loss Pill Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa GLP-1 Weight Loss Pill Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. GLP-1 Weight Loss Pill Value Chain Figure 126. Manufacturing Cost Structure Figure 127. GLP-1 Weight Loss Pill Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Clinic
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Novo Nordisk
  • Reddy's Laboratories
  • Imeik
  • Aurisco Pharmaceuticals
  • Borui Pharmaceuticals
  • Gan & Lee Pharmaceuticals
  • Hansoh Pharmaceuticals
  • Hengrui Medicine
  • Huadong Medicine
  • Eli Lilly
  • Merck
  • Shanghai Benemae Biopharmaceuticals Co., Ltd.
  • CSPC Pharmaceuticals
  • Sihuan Pharmaceuticals
  • Wanbang Biopharma
  • Innovent Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GLP-1 Weight Loss Pill Sales Value (2021-2032)
  4. 1.2.2 Global GLP-1 Weight Loss Pill Sales Volume (2021-2032)
  5. 1.2.3 Global GLP-1 Weight Loss Pill Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 GLP-1 Weight Loss Pill Market Dynamics
  1. 2.1 GLP-1 Weight Loss Pill Industry Trends
  2. 2.2 GLP-1 Weight Loss Pill Industry Drivers
  3. 2.3 GLP-1 Weight Loss Pill Industry Opportunities and Challenges
  4. 2.4 GLP-1 Weight Loss Pill Industry Restraints
3 GLP-1 Weight Loss Pill Market by Company
  1. 3.1 Global GLP-1 Weight Loss Pill Company Revenue Ranking in 2025
  2. 3.2 Global GLP-1 Weight Loss Pill Revenue by Company (2021-2026)
  3. 3.3 Global GLP-1 Weight Loss Pill Sales Volume by Company (2021-2026)
  4. 3.4 Global GLP-1 Weight Loss Pill Average Price by Company (2021-2026)
  5. 3.5 Global GLP-1 Weight Loss Pill Company Ranking (2024-2026)
  6. 3.6 Global GLP-1 Weight Loss Pill Company Manufacturing Base and Headquarters
  7. 3.7 Global GLP-1 Weight Loss Pill Company Product Type and Application
  8. 3.8 Global GLP-1 Weight Loss Pill Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global GLP-1 Weight Loss Pill Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 GLP-1 Weight Loss Pill Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 GLP-1 Weight Loss Pill Market by Type
  1. 4.1 GLP-1 Weight Loss Pill Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global GLP-1 Weight Loss Pill Sales Volume by Type
  5. 4.2.1 Global GLP-1 Weight Loss Pill Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global GLP-1 Weight Loss Pill Sales Volume by Type (2021-2032)
  7. 4.2.3 Global GLP-1 Weight Loss Pill Sales Volume Share by Type (2021-2032)
  8. 4.3 Global GLP-1 Weight Loss Pill Sales Value by Type
  9. 4.3.1 Global GLP-1 Weight Loss Pill Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global GLP-1 Weight Loss Pill Sales Value by Type (2021-2032)
  11. 4.3.3 Global GLP-1 Weight Loss Pill Sales Value Share by Type (2021-2032)
5 GLP-1 Weight Loss Pill Market by Application
  1. 5.1 GLP-1 Weight Loss Pill Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global GLP-1 Weight Loss Pill Sales Volume by Application
  7. 5.2.1 Global GLP-1 Weight Loss Pill Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global GLP-1 Weight Loss Pill Sales Volume by Application (2021-2032)
  9. 5.2.3 Global GLP-1 Weight Loss Pill Sales Volume Share by Application (2021-2032)
  10. 5.3 Global GLP-1 Weight Loss Pill Sales Value by Application
  11. 5.3.1 Global GLP-1 Weight Loss Pill Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global GLP-1 Weight Loss Pill Sales Value by Application (2021-2032)
  13. 5.3.3 Global GLP-1 Weight Loss Pill Sales Value Share by Application (2021-2032)
6 GLP-1 Weight Loss Pill Regional Sales and Value Analysis
  1. 6.1 Global GLP-1 Weight Loss Pill Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global GLP-1 Weight Loss Pill Sales by Region (2021-2032)
  3. 6.2.1 Global GLP-1 Weight Loss Pill Sales by Region: 2021-2026
  4. 6.2.2 Global GLP-1 Weight Loss Pill Sales by Region (2027-2032)
  5. 6.3 Global GLP-1 Weight Loss Pill Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global GLP-1 Weight Loss Pill Sales Value by Region (2021-2032)
  7. 6.4.1 Global GLP-1 Weight Loss Pill Sales Value by Region: 2021-2026
  8. 6.4.2 Global GLP-1 Weight Loss Pill Sales Value by Region (2027-2032)
  9. 6.5 Global GLP-1 Weight Loss Pill Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America GLP-1 Weight Loss Pill Sales Value (2021-2032)
  12. 6.6.2 North America GLP-1 Weight Loss Pill Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe GLP-1 Weight Loss Pill Sales Value (2021-2032)
  15. 6.7.2 Europe GLP-1 Weight Loss Pill Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific GLP-1 Weight Loss Pill Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific GLP-1 Weight Loss Pill Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America GLP-1 Weight Loss Pill Sales Value (2021-2032)
  21. 6.9.2 South America GLP-1 Weight Loss Pill Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa GLP-1 Weight Loss Pill Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa GLP-1 Weight Loss Pill Sales Value Share by Country, 2025 VS 2032
7 GLP-1 Weight Loss Pill Country-level Sales and Value Analysis
  1. 7.1 Global GLP-1 Weight Loss Pill Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global GLP-1 Weight Loss Pill Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global GLP-1 Weight Loss Pill Sales by Country (2021-2032)
  4. 7.3.1 Global GLP-1 Weight Loss Pill Sales by Country (2021-2026)
  5. 7.3.2 Global GLP-1 Weight Loss Pill Sales by Country (2027-2032)
  6. 7.4 Global GLP-1 Weight Loss Pill Sales Value by Country (2021-2032)
  7. 7.4.1 Global GLP-1 Weight Loss Pill Sales Value by Country (2021-2026)
  8. 7.4.2 Global GLP-1 Weight Loss Pill Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt GLP-1 Weight Loss Pill Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt GLP-1 Weight Loss Pill Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt GLP-1 Weight Loss Pill Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novo Nordisk
  2. 8.1.1 Novo Nordisk Company Information
  3. 8.1.2 Novo Nordisk Business Overview
  4. 8.1.3 Novo Nordisk GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novo Nordisk GLP-1 Weight Loss Pill Product Portfolio
  6. 8.1.5 Novo Nordisk Recent Developments
  7. 8.2 Reddy's Laboratories
  8. 8.2.1 Reddy's Laboratories Company Information
  9. 8.2.2 Reddy's Laboratories Business Overview
  10. 8.2.3 Reddy's Laboratories GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Reddy's Laboratories GLP-1 Weight Loss Pill Product Portfolio
  12. 8.2.5 Reddy's Laboratories Recent Developments
  13. 8.3 Imeik
  14. 8.3.1 Imeik Company Information
  15. 8.3.2 Imeik Business Overview
  16. 8.3.3 Imeik GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Imeik GLP-1 Weight Loss Pill Product Portfolio
  18. 8.3.5 Imeik Recent Developments
  19. 8.4 Aurisco Pharmaceuticals
  20. 8.4.1 Aurisco Pharmaceuticals Company Information
  21. 8.4.2 Aurisco Pharmaceuticals Business Overview
  22. 8.4.3 Aurisco Pharmaceuticals GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Aurisco Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
  24. 8.4.5 Aurisco Pharmaceuticals Recent Developments
  25. 8.5 Borui Pharmaceuticals
  26. 8.5.1 Borui Pharmaceuticals Company Information
  27. 8.5.2 Borui Pharmaceuticals Business Overview
  28. 8.5.3 Borui Pharmaceuticals GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Borui Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
  30. 8.5.5 Borui Pharmaceuticals Recent Developments
  31. 8.6 Gan & Lee Pharmaceuticals
  32. 8.6.1 Gan & Lee Pharmaceuticals Company Information
  33. 8.6.2 Gan & Lee Pharmaceuticals Business Overview
  34. 8.6.3 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
  36. 8.6.5 Gan & Lee Pharmaceuticals Recent Developments
  37. 8.7 Hansoh Pharmaceuticals
  38. 8.7.1 Hansoh Pharmaceuticals Company Information
  39. 8.7.2 Hansoh Pharmaceuticals Business Overview
  40. 8.7.3 Hansoh Pharmaceuticals GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hansoh Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
  42. 8.7.5 Hansoh Pharmaceuticals Recent Developments
  43. 8.8 Hengrui Medicine
  44. 8.8.1 Hengrui Medicine Company Information
  45. 8.8.2 Hengrui Medicine Business Overview
  46. 8.8.3 Hengrui Medicine GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Hengrui Medicine GLP-1 Weight Loss Pill Product Portfolio
  48. 8.8.5 Hengrui Medicine Recent Developments
  49. 8.9 Huadong Medicine
  50. 8.9.1 Huadong Medicine Company Information
  51. 8.9.2 Huadong Medicine Business Overview
  52. 8.9.3 Huadong Medicine GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Huadong Medicine GLP-1 Weight Loss Pill Product Portfolio
  54. 8.9.5 Huadong Medicine Recent Developments
  55. 8.10 Eli Lilly
  56. 8.10.1 Eli Lilly Company Information
  57. 8.10.2 Eli Lilly Business Overview
  58. 8.10.3 Eli Lilly GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Eli Lilly GLP-1 Weight Loss Pill Product Portfolio
  60. 8.10.5 Eli Lilly Recent Developments
  61. 8.11 Merck
  62. 8.11.1 Merck Company Information
  63. 8.11.2 Merck Business Overview
  64. 8.11.3 Merck GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Merck GLP-1 Weight Loss Pill Product Portfolio
  66. 8.11.5 Merck Recent Developments
  67. 8.12 Shanghai Benemae Biopharmaceuticals Co., Ltd.
  68. 8.12.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
  69. 8.12.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. Business Overview
  70. 8.12.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Pill Product Portfolio
  72. 8.12.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments
  73. 8.13 CSPC Pharmaceuticals
  74. 8.13.1 CSPC Pharmaceuticals Company Information
  75. 8.13.2 CSPC Pharmaceuticals Business Overview
  76. 8.13.3 CSPC Pharmaceuticals GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 CSPC Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
  78. 8.13.5 CSPC Pharmaceuticals Recent Developments
  79. 8.14 Sihuan Pharmaceuticals
  80. 8.14.1 Sihuan Pharmaceuticals Company Information
  81. 8.14.2 Sihuan Pharmaceuticals Business Overview
  82. 8.14.3 Sihuan Pharmaceuticals GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Sihuan Pharmaceuticals GLP-1 Weight Loss Pill Product Portfolio
  84. 8.14.5 Sihuan Pharmaceuticals Recent Developments
  85. 8.15 Wanbang Biopharma
  86. 8.15.1 Wanbang Biopharma Company Information
  87. 8.15.2 Wanbang Biopharma Business Overview
  88. 8.15.3 Wanbang Biopharma GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Wanbang Biopharma GLP-1 Weight Loss Pill Product Portfolio
  90. 8.15.5 Wanbang Biopharma Recent Developments
  91. 8.16 Innovent Biologics
  92. 8.16.1 Innovent Biologics Company Information
  93. 8.16.2 Innovent Biologics Business Overview
  94. 8.16.3 Innovent Biologics GLP-1 Weight Loss Pill Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Innovent Biologics GLP-1 Weight Loss Pill Product Portfolio
  96. 8.16.5 Innovent Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 GLP-1 Weight Loss Pill Value Chain Analysis
  2. 9.1.1 GLP-1 Weight Loss Pill Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 GLP-1 Weight Loss Pill Sales Mode & Process
  6. 9.2 GLP-1 Weight Loss Pill Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 GLP-1 Weight Loss Pill Distributors
  9. 9.2.3 GLP-1 Weight Loss Pill Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst